Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cotton Mouton Diagnostics has commercialized the CMD αBET® system, a rapid, sensitive, and sustainable platform for endotoxin detection in pharmaceutical products. The technology leverages magneto-optical detection with proprietary nanorod reporters to deliver quantitative results faster than traditional assays while using less reagent. The system is ISO 17025 accredited and FDA Part 11 ready, supporting both routine QC and method development/validation work. It is used across pharma manufacturing sites, QC labs, and R&D facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cotton Mouton Diagnostics.